ALD-1910
- Generic Name
- ALD-1910
A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine
- First Posted Date
- 2024-08-29
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 40
- Registration Number
- NCT06578585
- Locations
- πΊπΈ
Clinical Neuroscience Solutions, Orlando, Florida, United States
πΊπΈNeuroTrials Research, Atlanta, Georgia, United States
πΊπΈFuture Search Trials, Austin, Texas, United States
A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
- First Posted Date
- 2024-03-21
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 898
- Registration Number
- NCT06323928
- Locations
- π¨πΏ
Axon Clinical s r.o, Praha 5, Czechia
π¨πΏNeurologicka ordinace FORBELI sro, Praha 6, Czechia
π¨πΏInstitut neuropsychiatricke pece, Praha 8, Czechia
A Study Investigating the Movement of Lu AG09222 Into, Through, and Out of the Body of Healthy Caucasian, Chinese, and Japanese Participants
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2022-11-10
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 52
- Registration Number
- NCT05304910
- Locations
- πΊπΈ
PAREXEL International, Glendale, California, United States
A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
- First Posted Date
- 2021-11-24
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 237
- Registration Number
- NCT05133323
- Locations
- πΊπΈ
Excell Research - ClinEdge - PPDS, Oceanside, California, United States
πΊπΈUNISON Clinical Trials (Shahram Jacobs md inc.), Sherman Oaks, California, United States
πΊπΈAllied Biomedical Research Institute, Miami, Florida, United States
A Trial to Learn More About Repeated Monthly Injections of Lu AG09222 in Participants With Allergies to Grass Pollen
- First Posted Date
- 2021-11-19
- Last Posted Date
- 2022-10-27
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 30
- Registration Number
- NCT05126316
- Locations
- π¬π§
St Pancras Clinical Research, London, United Kingdom
π¬π§Medicines Evaluation Unit, Manchester, United Kingdom
A Single Dose Study of Lu AG09222 in a Headache Model With Healthy Subjects
- First Posted Date
- 2021-07-26
- Last Posted Date
- 2022-01-19
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 25
- Registration Number
- NCT04976309
- Locations
- π©π°
Danish Headache Center Rigshospitalet Glostrup, Glostrup, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.